Press Releases

2025

Antibiotice Iași Strengthens Its Partnership with the UK Public Healthcare System through a New Tender Win

Romanian Tradition and Continuity. 100 Years of the Romanian Patriarchate | 70 Years of Antibiotice SA

Antibiotice Iași: Balanced Development, Strategic Investments, and International Expansion

Antibiotice Iași Launches 3 New Products at the National Conference on Practical Phytotherapy and Nutraceuticals

Antibiotice Iași Invests €1.5 Million to Support Youth Employment Integration

The power of action lies in our hands! Antibiotice Iași invests in the education of gifted children from rural areas

Antibiotice Iași Employees Save 240 Lives Together with the Local Community through the Campaign “Donate Blood! Save a Life!”

Antibiotice Iași Welcomes IBM Research Vice President, Jason Silbergleit Opportunities for Innovation in the Romanian Pharmaceutical Industry

Excellence Continues: A Perfect 10 in the VEKTOR Ranking for Antibiotice Iași, Six Years in a Row

Antibiotice Iași: A Talent Incubator for the Pharmaceutical Industry in Moldova

2024

Antibiotice Employees Create 1,000 Smiles for Underprivileged Children in 12 Years of Holiday Giving

Antibiotice Iași Awarded Gold Level Recognition in the Romania Corporate Sustainability & Transparency INDEX Competition

Antibiotice Employees Plant 500 Trees

Increased Profitability in the First 9 Months of 2024 Strengthens Antibiotice Iași’s Business

Antibiotice Iași, ranked 1st among the most competitive companies in Romania for over 20 years

Antibiotice employees and their children learn first aid measures in emergency situations

Antibiotice organized the second edition of the project “We responsibly collect expired medicines!” at the company’s headquarters in Iași

Campaign “Donate Blood! Give Your Heart for Life!” Saves 270 Lives

Press release financial results of the first semester of 2024

Antibiotice Iasi invests in digitalization for the transition to a sustainable business

The Antibiotice Iași business growth by 24% in 2023 strengthens the company’s development

Antibiotice Iasi has commissioned a 2.5 MW photovoltaic plant, financed by the RRRP, which will provide over 25% of the electricity requirements

2023

First InvestEU agreement in Romania provides €25 million in EIB financing to boost security of supply for medicines

Antibiotice Iași Wins a New Tender Launched by the National Health Service of the United Kingdom

The economic and financial results recorded in 2022

The European Investment Bank and Antibiotice SA signed an advisory service agreement for the strategic development of the industrial site of the company

2020

Press release – Antibiotice SA won EU auction for the antibiotic AmoxiPlus®

Press release – Financial results at 6 months (14.08.2020)

2019

Q3 Financial results (11.15.2019)

Q2 Financial results

The main decisions of the General Meeting of the Shareholders of the Antibiotic company, held today, April 18, 2019

2018

Financial results for 9 months 2018 (14.11)

Press release – Antibiotics of the Third Millennium – debate with international participation

Press release – Preliminary financial results 2017 (15.02)

Press Releases – Financial Results 2017 – OGMS Decisions (26.04)

Press release – Financial results at 6 months (14.08)